NCT02025686View on ClinicalTrials.gov

Hyperbaric Oxygen Therapy Attenuates Central Sensitization Induced by a Thermal Injury in Human Volunteers (HBO)

NACompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

August 31, 2012

Study Completion Date

October 31, 2012

Conditions
PainInflammationHyperalgesia
Interventions
DRUG

Hyperbaric Oxygen

Subjects will breathe oxygen (FIO2 = 1.0) at 2.4 ATA in a hyperbaric chamber after the tonic heat stimulations. The duration of oxygen exposure is 90 min.

OTHER

Normal ambient conditions

Normal ambient conditions (1 ATA, FIO2 = 0.21)

Trial Locations (1)

2100

Copenhagen University Hospital, Rigshospitalet, Copenhagen

All Listed Sponsors
lead

Per Rotbøll Nielsen

OTHER

NCT02025686 - Hyperbaric Oxygen Therapy Attenuates Central Sensitization Induced by a Thermal Injury in Human Volunteers (HBO) | Biotech Hunter | Biotech Hunter